Dexmedetomidine Hydrochloride Injection — FDA Drug Shortage

To Be Discontinued — Slayback Pharma

The FDA lists a drug shortage record for Dexmedetomidine Hydrochloride Injection (injection) from Slayback Pharma with status To Be Discontinued. The shortage was first posted on Jun 5, 2026.

Shortage details

Status
To Be Discontinued
Company
Slayback Pharma
Package NDC
71225-126-05
Dosage Form
Injection
Presentation
Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 71225-126-05)
Initial Posting
Jun 5, 2026

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.